Explore how our CDMO services can take your biologic further at BIO 2024. Schedule a meeting.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Comparator sourcing: Leveraging the Bolar exemption to accelerate market access for generic and biosimilar products
Whitepaper
This whitepaper provides insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies. Thermo Fisher's Comparator team has the required expertise to leverage the Bolar exemption, providing clients early access to generic / biosimilar drugs.